| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | 0 | 19.888 | 14.416 | 3.600 | 2.306 | 713 |
| Total Income - EUR | - | - | - | - | 9.015 | 42.103 | 14.416 | 3.600 | 2.306 | 713 |
| Total Expenses - EUR | - | - | - | - | 10.116 | 26.240 | 13.082 | 8.846 | 1.948 | 643 |
| Gross Profit/Loss - EUR | - | - | - | - | -1.102 | 15.863 | 1.334 | -5.246 | 357 | 70 |
| Net Profit/Loss - EUR | - | - | - | - | -1.102 | 15.665 | 910 | -5.348 | 303 | 59 |
| Employees | - | - | - | - | 3 | 3 | 1 | 0 | 0 | 0 |
Check the financial reports for the company - Petcrissmed S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | 1.001 | 6.953 | 5.205 | 4.258 | 3.403 | 2.973 |
| Current Assets | - | - | - | - | 24.045 | 11.732 | 10.199 | 5.920 | 7.389 | 8.001 |
| Inventories | - | - | - | - | 0 | 944 | 923 | 926 | 923 | 918 |
| Receivables | - | - | - | - | 7.864 | 19 | 857 | 18 | 18 | 18 |
| Cash | - | - | - | - | 16.182 | 10.769 | 8.419 | 4.976 | 6.448 | 7.065 |
| Shareholders Funds | - | - | - | - | -1.060 | 14.625 | 15.211 | 9.911 | 10.184 | 10.186 |
| Social Capital | - | - | - | - | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | 3.861 | 4.452 | 192 | 268 | 609 | 789 |
| Income in Advance | - | - | - | - | 22.244 | -393 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8699 - 8699" | |||||||||
| CAEN Financial Year |
8690
|
|||||||||
Comments - Petcrissmed S.r.l.